(Q34545862)

English

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

Radical nephrectomy

1 reference

based on heuristic

inferred from title

kidney neoplasm

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

Jörn von Wietersheim

10

object named as

Jörn von Wietersheim

0 references

author name string

Dieter Jocham

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Axel Richter

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lothar Hoffmann

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Klaus Iwig

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dirk Fahlenkamp

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Günther Zakrzewski

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eberhard Schmitt

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Thomas Dannenberg

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Walter Lehmacher

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jörn von Wietersheim

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christian Doehn

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9409

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

594-599

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of intercellular adhesion molecule-1 (ICAM-1) antigen expression and shedding by interferon-gamma and phorbol ester in human renal carcinoma cell cultures: relation to peripheral blood mononuclear cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and release of intercellular adhesion molecule-1 in renal-cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-nutritive bioactive food constituents of plants: tocopherols (vitamin E).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines in oncology: background and clinical potential

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surrogate markers of response to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915590-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)15590-6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34545862&oldid=2070850286"